Trauma & major bleeding

Prothrombin Complex Concentrate vs Conservative Management in Intracerebral Hemorrhage (ICH) Associated With Direct Oral Anticoagulants

JAMA Netw OpenPublished Retrospective cohort study

An erratum to this article was published (JAMA Netw Open, 5 Feb 2024 ↗)

Main finding · Good neurological recoveryResult — go to the resultAdjusted odds ratio 0.62 95% CI 0.33–1.16

Authors' conclusion

PCC treatment was not associated with improved functional outcome, hematoma expansion, or mortality.

Study context

Population
Patients with Direct Oral Anticoagulant (DOAC)-associated ICH, Hong Kong, January 1, 2016, to December 31, 2021
Participants
232 patients
Exposure
Prothrombin complex concentrate (PCC) vs conservative management
  • PCCn = 102
  • Conservativen = 116reference
Outcome
Modified Rankin scale of 0 to 3 or returning to baseline functional status
Follow-up
3 months
Methodological detailspopulation-based, propensity score-weighted
  • Population-based
  • Propensity score-weighted

Main finding

Good neurological recovery

Adjusted odds ratio

0.62

95% CI 0.33–1.16

P = 0.14

PCC vs Conservative
aOR 0.62 (95% CI 0.33–1.16); P = 0.14

As reported in the abstract

Good neurological recovery, overall
74 (31%)

Observational data: associations, not effects.

Secondary outcomes

OutcomeaOR (95% CI)P value
Mortality at 90 days1.03 (0.70–1.53)P = 0.88
In-hospital mortality1.11 (0.69–1.79)P = 0.66
Hematoma expansion0.94 (0.38–2.31)P = 0.90
Mortality at 90 days — Died within 90 days, overall
92 (39%)

Factors associated with outcomes (unweighted)

Higher baseline hematoma volume, lower GCS and intraventricular hemorrhage associated with lower odds of good neurological outcome but not hematoma expansion

Original publication

Prothrombin Complex Concentrate vs Conservative Management in ICH Associated With Direct Oral Anticoagulants. JAMA Netw Open. Published 5 February 2024. doi:10.1001/jamanetworkopen.2023.54916

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.